Aged
Androgen Antagonists/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Cause of Death
*Chemoradiotherapy
Disease Progression
Humans
Male
Middle Aged
Neoplasm Grading
Prostate-Specific Antigen/blood
Prostatic Neoplasms/mortality/pathology/*therapy
Radiotherapy Dosage
Survival Analysis
Treatment Outcome
